News|Articles|August 12, 2025
FDA Action Update, July 2025: Approval, Label Update, Complete Response Letter
Author(s)Isabella Ciccone, MPH
Catch up on any of the neurology news headlines you may have missed over the course of July 2025, compiled all into 1 place by the NeurologyLive® team.
Advertisement
Advertisement
The FDA was busy in July 2025, making a number of decisions on potential new therapeutic agents, including granting an approval, a clearance, a label update, and a priority review, issuing a complete response letter, and suspending a distribution.
Advertisement
Advertisement